(Q40388224)

English

Piperacillin/tazobactam versus cefepime for the empirical treatment of pediatric cancer patients with neutropenia and fever: a randomized and open-label study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Piperacillin/tazobactam versus cefepime for the empirical treatment of pediatric cancer patients with neutropenia and fever: a randomized and open-label study (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

piperacillin/tazobactam

1 reference

based on heuristic

inferred from title

author name string

Vedat Uygun

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Gulsun Tezcan Karasu

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Dilara Ogunc

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Akif Yesilipek

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Volkan Hazar

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

publication date

1 October 2009

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Pediatric Blood Cancer

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

53

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

610-614

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeits

1 reference

https://api.crossref.org/works/10.1002%2FPBC.22100

21 January 2018

Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey

1 reference

https://api.crossref.org/works/10.1002%2FPBC.22100

21 January 2018

Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Tre

1 reference

https://api.crossref.org/works/10.1002%2FPBC.22100

21 January 2018

Identifiers

10.1002/PBC.22100

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40388224&oldid=1896736687"